Evidence map›Paper›PMID 40396490›Full record

ArticleNucleic acids research2025

Retroviral adapters hijack the RNA helicase UPF1 in a CRM1/XPO1-dependent manner and reveal proviral roles of UPF1.

Léa Prochasson, Makram Mghezzi-Habellah, Armelle Roisin, Martine Palma, Jean-Philippe Robin, Stève de Bossoreille, David Cluet, Malèke Mouelhi, Didier Decimo, Alexandra Desrames and 8 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Léa ProchassonLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Makram Mghezzi-HabellahLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Armelle RoisinLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Martine PalmaUniversité de Lille, CNRS, Inserm, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.
Jean-Philippe RobinLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Stève de BossoreilleLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
David CluetLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Malèke MouelhiLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Didier DecimoCentre International de Recherche en Infectiologie (CIRI), Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon, Inserm U1111, CNRS UMR5308, F-69364 Lyon, France.
Alexandra DesramesInstitut Pasteur, Université Paris Cité, CNRS UMR3569, Biofilm and Viral Transmission team, Structural Virology Unit, F-75724 Paris, France.
Thibault ChazeInstitut Pasteur, Université Paris Cité, CNRS UAR2024, Proteomics Platform, Mass Spectrometry for Biology Unit, F-75015 Paris, France.
Mariette MatondoInstitut Pasteur, Université Paris Cité, CNRS UAR2024, Proteomics Platform, Mass Spectrometry for Biology Unit, F-75015 Paris, France.
Hélène DutartreCentre International de Recherche en Infectiologie (CIRI), Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon, Inserm U1111, CNRS UMR5308, F-69364 Lyon, France.
Maria-Isabel ThoulouzeInstitut Pasteur, Université Paris Cité, CNRS UMR3569, Biofilm and Viral Transmission team, Structural Virology Unit, F-75724 Paris, France.
Fabrice LejeuneUniversité de Lille, CNRS, Inserm, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France.ORCID 0000-0002-5132-3585
Pierre JalinotLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.
Stephane RetyLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.ORCID 0000-0002-2089-6727
Vincent MocquetLaboratoire de Biologie et Modélisation de la Cellule, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon 1, Inserm U1293, CNRS UMR5239, F-69364 Lyon, France.ORCID 0000-0003-4337-5278

Funding

Ames Research Center NASA PJA-20181207764-1ENS de LyonFrench Agence Nationale de Recherche sur le SIDA et les Hépatites Virales AO2913-01French Agence Nationale de Recherche sur le SIDA et les Hépatites Virales ECTZ75066French Agence Nationale de Recherche sur le SIDA et les Hépatites Virales ECTZ89398La Ligue contre le Cancerl'Institut Pasteur
6 · The paper itself

Abstract

The hijacking of CRM1 export is an important step of the retroviral replication cycle. Here, we investigated the consequences of this hijacking for the host. During HTLV-1 infection, we identified that this hijacking by the viral protein Rex favours the association between CRM1 and the RNA helicase UPF1, leading to a decreased affinity of UPF1 for cellular RNA and its nuclear retention. As a consequence, we found that the nonsense-mediated mRNA decay (NMD), known to have an antiviral function, was inhibited. Corroborating these results, we described a similar process with Rev, the functional homolog of Rex from HIV-1. Unexpectedly, we also found that, for HTLV-1, this process is coupled with the specific loading of UPF1 onto vRNA, independently of NMD. In this latter context, UPF1 positively regulates several steps of the viral replication cycle, from the nuclear export of vRNA to the production of mature viral particles.

Indexed as

Human T-lymphotropic virus 1KaryopherinsReceptors, Cytoplasmic and NuclearRNA HelicasesTrans-ActivatorsActive Transport, Cell NucleusCell NucleusExportin 1 ProteinHEK293 CellsHeLa CellsHumansNonsense Mediated mRNA DecayRNA, ViralVirus ReplicationExportin 1 ProteinKaryopherinsReceptors, Cytoplasmic and NuclearRNA HelicasesRNA, ViralTrans-ActivatorsUPF1 protein, human

Identifiers

PMID40396490
PMCPMC12093142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.